EPCLUSA SUPPORT PATH®
IS ON YOUR SIDE

If you’re seeking financial assistance or insurance support, EPCLUSA Support Path may be able to help.

EPCLUSA is a prescription medicine used to treat adults with chronic (lasting a long time) hepatitis C (Hep C) genotype 1, 2, 3, 4, 5, or 6 infection with or without cirrhosis (compensated). In those with advanced cirrhosis (decompensated), EPCLUSA is used with ribavirin.

Connect with EPCLUSA Support Path 1-855-7-MYPATH (1-855-769-7284)
SEE DETAILS ABOUT FINANCIAL ASSISTANCE AND INSURANCE SUPPORT

EPCLUSA is a prescription medicine used to treat adults with chronic (lasting a long time) hepatitis C (Hep C) genotype 1, 2, 3, 4, 5, or 6 infection with or without cirrhosis (compensated). In those with advanced cirrhosis (decompensated), EPCLUSA is used with ribavirin.

Important Safety Information

What is the most important information I should know about EPCLUSA?

EPCLUSA can cause serious side effects, including:

  • Hepatitis B virus reactivation: Before starting EPCLUSA treatment, your healthcare provider will do blood tests to check for hepatitis B infection. If you have ever had hepatitis B, the hepatitis B virus could become active again during and after treatment with EPCLUSA. This may cause serious liver problems including liver failure and death. If you are at risk, your healthcare provider will monitor you during and after taking EPCLUSA.

Continued below

FINANCIAL ASSISTANCE

INSURANCE SUPPORT

  • Some patients may need financial assistance to help reduce the cost of treatment. We’re here to help. EPCLUSA Support Path provides access to a live specialist who will work with you to understand your financial situation and evaluate possible options for you, such as:

    Co-pay Coupon

    Those who are eligible will receive a co-pay coupon to help reduce the cost of EPCLUSA.

    • You are not eligible if you are enrolled in a government healthcare prescription drug program such as Medicaid or Medicare Part D (including when you are in the coverage gap known as the “donut hole”).
    CHECK YOUR
    ELIGIBILITY NOW

    Other Financial Assistance

    If you are enrolled in a government healthcare prescription drug program, do not have insurance, or have private insurance that does not cover EPCLUSA, other financial assistance may be available. Speak with an EPCLUSA Support Path specialist at 1-855-7-MYPATH (1-855-769-7284) to learn more.

  • The insurance approval process can sometimes be difficult and confusing. EPCLUSA Support Path simplifies the treatment approval process by connecting you with a specialist who will help you navigate your insurance coverage.

    How we help

    • We’ll research and verify your benefits, then give you the information you need about your coverage options and policies
    • We can explain the prior authorization process and work with your Hep C Specialist’s office so they can submit to your insurance company on your behalf (a prior authorization is a step that some insurance companies require before they decide if they are going to pay for your medicine)
    • We may be able to provide assistance if an appeal to your insurance company is required

    Investigating your benefits

    To explore and understand your medication coverage, call EPCLUSA Support Path at 1-855-7-MYPATH (1-855-769-7284) and inform the EPCLUSA Support Path specialist that you want to perform a benefits investigation.

Unfamiliar with any terms regarding insurance & financial assistance?

DOWNLOAD THE EPCLUSA SUPPORT PATH GLOSSARY

SUPPORT AT EVERY STEP

The diagram below shows how the EPCLUSA treatment process typically works. Your individual experience may vary, but Onward™ and EPCLUSA Support Path will be there to assist you at every step.

Understanding the EPCLUSA treatment process

  • Insurance approval*:

    3–4 weeks

    This is when you find out if your insurance company approves your prescription and what your financial assistance options may be.

  • Treatment:

    12 weeks

    EPCLUSA prescriptions are usually filled one month at a time.

    Some health plans may require blood tests at certain points to see how you’re responding to treatment.

  • Post-treatment follow-up:

    3 months

    EPCLUSA Educators will be just a phone call away while you wait to see if you are cured.

*Insurance approval, which may require a process known as prior authorization, is a step that some insurance companies require before they decide if they are going to pay for your medicine.

Cure means the Hep C virus is not detected in the blood when measured three months after treatment is completed.

Important Safety Information

What should I tell my healthcare provider before taking EPCLUSA?

  • If you have: ever had hepatitis B infection, liver problems other than hepatitis C infection; severe kidney problems or are on dialysis; any other medical condition; or if you are pregnant or breastfeeding, or plan to become pregnant or breastfeed. It is not known if EPCLUSA will harm your unborn baby. If you take EPCLUSA with ribavirin, you should also read the ribavirin Medication Guide for important pregnancy-related information.
  • Tell your healthcare provider and pharmacist about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. EPCLUSA and certain other medicines may affect each other, or may cause side effects. Tell your healthcare provider if you take any medicines containing tenofovir disoproxil fumarate (ATRIPLA®, COMPLERA®, STRIBILD®, TRUVADA®, VIREAD®).

What are the possible side effects of EPCLUSA?

  • Serious side effects may also include: Slow heart rate (bradycardia): EPCLUSA, when taken with amiodarone (Cordarone®, Nexterone®, Pacerone®), a medicine used to treat certain heart problems, may cause slow heart rate. In some cases slow heart rate has led to death or the need for a pacemaker when amiodarone is taken with medicines containing sofosbuvir and another antiviral medicine. Get medical help right away if you take amiodarone with EPCLUSA and get any of the following symptoms: fainting or near-fainting, dizziness or lightheadedness, not feeling well, weakness, extreme tiredness, shortness of breath, chest pains, confusion, or memory problems.

The most common side effects of EPCLUSA include headache and tiredness. When EPCLUSA is used with ribavirin for patients with advanced cirrhosis, side effects also include anemia, nausea, insomnia, and diarrhea.

Please see Important Facts about EPCLUSA including Important Warning.

EPCLUSA is a prescription medicine used to treat adults with chronic (lasting a long time) hepatitis C (Hep C) genotype 1, 2, 3, 4, 5, or 6 infection with or without cirrhosis (compensated). In those with advanced cirrhosis (decompensated), EPCLUSA is used with ribavirin.

Important Safety Information

What is the most important information I should know about EPCLUSA?

EPCLUSA can cause serious side effects, including:

  • Hepatitis B virus reactivation: Before starting EPCLUSA treatment, your healthcare provider will do blood tests to check for hepatitis B infection. If you have ever had hepatitis B, the hepatitis B virus could become active again during and after treatment with EPCLUSA. This may cause serious liver problems including liver failure and death. If you are at risk, your healthcare provider will monitor you during and after taking EPCLUSA.

What should I tell my healthcare provider before taking EPCLUSA?

  • If you have: ever had hepatitis B infection, liver problems other than hepatitis C infection; severe kidney problems or are on dialysis; any other medical condition; or if you are pregnant or breastfeeding, or plan to become pregnant or breastfeed. It is not known if EPCLUSA will harm your unborn baby. If you take EPCLUSA with ribavirin, you should also read the ribavirin Medication Guide for important pregnancy-related information.
  • Tell your healthcare provider and pharmacist about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. EPCLUSA and certain other medicines may affect each other, or may cause side effects. Tell your healthcare provider if you take any medicines containing tenofovir disoproxil fumarate (ATRIPLA®, COMPLERA®, STRIBILD®, TRUVADA®, VIREAD®).

What are the possible side effects of EPCLUSA?

  • Serious side effects may also include: Slow heart rate (bradycardia): EPCLUSA, when taken with amiodarone (Cordarone®, Nexterone®, Pacerone®), a medicine used to treat certain heart problems, may cause slow heart rate. In some cases slow heart rate has led to death or the need for a pacemaker when amiodarone is taken with medicines containing sofosbuvir and another antiviral medicine. Get medical help right away if you take amiodarone with EPCLUSA and get any of the following symptoms: fainting or near-fainting, dizziness or lightheadedness, not feeling well, weakness, extreme tiredness, shortness of breath, chest pains, confusion, or memory problems.

The most common side effects of EPCLUSA include headache and tiredness. When EPCLUSA is used with ribavirin for patients with advanced cirrhosis, side effects also include anemia, nausea, insomnia, and diarrhea.

Please see Important Facts about EPCLUSA including Important Warning.

Looking for ongoing support throughout treatment with EPCLUSA? Sign up for Onward to get step‑by‑step guidance on the insurance approval process and more.

MOVE ONE STEP CLOSER